| ²é¿´: 2075 | »Ø¸´: 9 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
chaoyang0707ͳæ (СÓÐÃûÆø)
|
[½»Á÷]
¡¾ÇóÖú¡¿Ò©Æ·µÄÔÑг§¼ÒÔõô²éÕÒ£¿ ÒÑÓÐ4È˲ÎÓë
|
||
| Âé·³´ó¼Ò°ï¹þ棬ÎÒÊǸöг棬ÎÒÏëÕÒ°¢ÆæÃ¹ËØ·ÖɢƬ»ò°¢ÆæÃ¹ËصÄÔÑг§¼Ò£¬ÇëÖªµÀµÄÀϳæÃÇ£¬Äܰï¹þ棬·Ç³£¸Ðл£¡£¡£¡ |
» ²ÂÄãϲ»¶
ÄÔ¹£ÔõôÖÎÁÆ
ÒѾÓÐ3È˻ظ´
ÄÔ¹£ÔõôÖÎÁÆ
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ67È˻ظ´
ÈçºÎ¸ßЧµÄ²âÁ¿ÏÙ²¡¶¾µÄÁ£¾¶ºÍµçλ
ÒѾÓÐ0È˻ظ´
ÉúÎï×éÖ¯ÖÐÓÐÄ¿±ê·ÖÎöÎרÊôÐÔÔõô×ö
ÒѾÓÐ0È˻ظ´
26ÔÚÖ°É격¡ªÉúÎïÓëÒ½Ò©¡ª¿¹Ìå/ADCÒ©Îï·½Ïò£¬½Õ㻦£¬ÓÐÏîÄ¿£¬¿É´ø×Ê¡£
ÒѾÓÐ1È˻ظ´
288·ÖÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
Ò»Ö¾Ô¸ËÕÖÝ´óѧ ÉúÎï¼¼ÊõÓ빤³Ì£¨086001£© ³õÊÔ323·Ö£¬Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ÈýÄêʵÑéÊÒ¹¤×÷¾Àú£¬Ò»Ö¾Ô¸»ªÖÐũҵ´óѧ΢ÉúÎ×Ü·Ö288Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖúÔÑÐҩƷ˵Ã÷Êé¼°ÖÊÁ¿±ê×¼
ÒѾÓÐ4È˻ظ´
ÈçºÎ²éѯ¹úÍ⣨ÃÀ¹ú£©Ò©Æ·µÄÏúÁ¿ºÍÊۼ۵ı仯£¿
ÒѾÓÐ19È˻ظ´
ÔÑÐÒ©¹úÍâרÀû¶ÔÒ½Ò©Ñз¢µÄÓ°Ïì
ÒѾÓÐ8È˻ظ´
ͬ×åרÀûÔõô²é£¿
ÒѾÓÐ6È˻ظ´
´ó¼Ò¶¼ÊÇÈçºÎ²éÕÒÒ»ÀàÒ©Îï½üÁ½ÄêÉÏÊеÄÐÂÒ©µÄ
ÒѾÓÐ6È˻ظ´
ÔÚÄÄÀï¿ÉÒÔ²éѯҩƷרÀûÓÐЧÆÚѽ£¿¹úÍâµÄÒ©Æ·
ÒѾÓÐ7È˻ظ´
FDAÒ©Æ·ÐÅÏ¢¼ìË÷ÕªÒª
ÒѾÓÐ235È˻ظ´
Ò©Æ·ÔÑг§¼ÒµÄ²éѯ
ÒѾÓÐ15È˻ظ´
ÔÚÄÄÀïÄܲ鵽ÆäËû¹«Ë¾ÊÜÀíµÄÒ©Æ·µÄ¹æ¸ñ
ÒѾÓÐ5È˻ظ´
Ôõô²éµÂ¹ú¡¢·¨¹úºÍÒâ´óÀûµÄÉÏÊÐÒ©Æ·ÐÅÏ¢
ÒѾÓÐ5È˻ظ´
ÐÂÊÖ¹òÇó¸÷λ´óÏÀ£º×öÁùÀà·ÂÖÆÒ©£¬ÔÑг§¼ÒµÄÖÆ¼Á´¦·½Ó¦¸ÃÈ¥ÄÄÀï²éÄØ£¿
ÒѾÓÐ23È˻ظ´
ÈçºÎ²éÕÒÔÑе¥Î»£¿
ÒѾÓÐ5È˻ظ´
Ò©Æ·´¦·½¹¤ÒÕÑо¿
ÒѾÓÐ206È˻ظ´
ÔÁÏÒ©×¢²áÐèÒªÕÒÔÑг§¼ÒÂð£¿
ÒѾÓÐ35È˻ظ´
ÇëÎÊÒÔÏÂÒ©ÎïµÄÔÑг§¼Ò
ÒѾÓÐ6È˻ظ´
ÈçºÎ²éÕÒijҩÎïÔÚ¹úÍâµÄÉÏÊÐÐÅÏ¢
ÒѾÓÐ4È˻ظ´
ÇëÎÊÔõô²éij¸öÒ©ÎïÔÚÊг¡ÉϵÄÏúÊÛÇé¿ö
ÒѾÓÐ7È˻ظ´
Ôõô²éÔÑÐÒ©Æ·°¡ ÔÚÄIJéÄØ
ÒѾÓÐ10È˻ظ´
¡¾ÇóÖú¡¿ÈçºÎ²éѯҩƷÕýÔÚÉ걨µÄ³§¼ÒÇé¿ö
ÒѾÓÐ7È˻ظ´
¡¾ÇóÖú¡¿Ã»ÓÐÁÐÈë¡¶ÖйúÒ©µä¡·µÄÒ©Æ·±ê×¼Ôõô²éѯ
ÒѾÓÐ5È˻ظ´
¡¾ÇóÖú¡¿ÔÁÏÒ©ÈçºÎ²éѯÔÉú²ú³§¼Ò£¿
ÒѾÓÐ20È˻ظ´
¡¾ÇóÖú¡¿ÈçºÎ²éѯһ¸öÒ©Æ·µÄÔÑг§¼Ò£¿
ÒѾÓÐ10È˻ظ´

tianhua1211
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 21344.9
- ºì»¨: 2
- Ìû×Ó: 1835
- ÔÚÏß: 116.7Сʱ
- ³æºÅ: 951853
- ×¢²á: 2010-02-03
- ÐÔ±ð: MM
- רҵ: Ò©Îï×ÊÔ´
|
11 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 050809 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ INJECTABLE; INJECTION ¹æ¸ñ EQ 500MG BASE/VIAL ÖÎÁƵÈЧ´úÂë AP ²Î±ÈÒ©Îï ÊÇ Åú×¼ÈÕÆÚ 2006/12/19 ÉêÇë»ú¹¹ TEVA PARENTERAL MEDICINES INC 12 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 050809 ²úÆ·ºÅ 002 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ INJECTABLE; INJECTION ¹æ¸ñ EQ 2.5GM BASE/VIAL ÖÎÁƵÈЧ´úÂë ²Î±ÈÒ©Îï ÊÇ Åú×¼ÈÕÆÚ 2006/12/19 ÉêÇë»ú¹¹ TEVA PARENTERAL MEDICINES INC 13 Ò©Æ·Ãû³Æ AZASITE ÉêÇëºÅ 050810 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ SOLUTION/DROPS; OPHTHALMIC ¹æ¸ñ 1% ÖÎÁƵÈЧ´úÂë ²Î±ÈÒ©Îï ÊÇ Åú×¼ÈÕÆÚ 2007/04/27 ÉêÇë»ú¹¹ INSPIRE PHARMACEUTICALS INC 14 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065150 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 600MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2005/11/14 ÉêÇë»ú¹¹ TEVA PHARMACEUTICALS USA INC 15 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065153 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 250MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2005/11/14 ÉêÇë»ú¹¹ TEVA PHARMACEUTICALS USA INC 16 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065179 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ INJECTABLE; INJECTION ¹æ¸ñ EQ 500MG BASE/VIAL ÖÎÁƵÈЧ´úÂë AP ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2005/12/13 ÉêÇë»ú¹¹ APP PHARMACEUTICALS LLC 17 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065193 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 500MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2005/11/14 ÉêÇë»ú¹¹ TEVA PHARMACEUTICALS USA INC 18 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065209 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 600MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2005/11/14 ÉêÇë»ú¹¹ SANDOZ INC 19 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065211 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 250MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2005/11/14 ÉêÇë»ú¹¹ SANDOZ INC 20 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065212 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 500MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2005/11/14 ÉêÇë»ú¹¹ SANDOZ INC |
4Â¥2010-09-15 10:27:23
earrier
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 760.3
- ºì»¨: 1
- Ìû×Ó: 163
- ÔÚÏß: 41.4Сʱ
- ³æºÅ: 247429
- ×¢²á: 2006-05-01
- ÐÔ±ð: MM
- רҵ: Ò©¼Áѧ
2Â¥2010-09-15 09:27:14
tianhua1211
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 21344.9
- ºì»¨: 2
- Ìû×Ó: 1835
- ÔÚÏß: 116.7Сʱ
- ³æºÅ: 951853
- ×¢²á: 2010-02-03
- ÐÔ±ð: MM
- רҵ: Ò©Îï×ÊÔ´
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
|
1 Ò©Æ·Ãû³Æ ZITHROMAX ÉêÇëºÅ 050670 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ Í£Ö¹ÉÏÊÐ ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ CAPSULE; ORAL ¹æ¸ñ EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** ÖÎÁƵÈЧ´úÂë ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 1991/11/01 ÉêÇë»ú¹¹ PFIZER CHEMICALS DIV PFIZER INC 2 Ò©Æ·Ãû³Æ ZITHROMAX ÉêÇëºÅ 050693 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ FOR SUSPENSION; ORAL ¹æ¸ñ EQ 1GM BASE/PACKET ÖÎÁƵÈЧ´úÂë ²Î±ÈÒ©Îï ÊÇ Åú×¼ÈÕÆÚ 1994/09/28 ÉêÇë»ú¹¹ PFIZER CENTRAL RESEARCH 3 Ò©Æ·Ãû³Æ ZITHROMAX ÉêÇëºÅ 050710 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ FOR SUSPENSION; ORAL ¹æ¸ñ EQ 100MG BASE/5ML ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 1995/10/19 ÉêÇë»ú¹¹ PFIZER CHEMICALS DIV PFIZER INC 4 Ò©Æ·Ãû³Æ ZITHROMAX ÉêÇëºÅ 050710 ²úÆ·ºÅ 002 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ FOR SUSPENSION; ORAL ¹æ¸ñ EQ 200MG BASE/5ML ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ÊÇ Åú×¼ÈÕÆÚ 1995/10/19 ÉêÇë»ú¹¹ PFIZER CHEMICALS DIV PFIZER INC 5 Ò©Æ·Ãû³Æ ZITHROMAX ÉêÇëºÅ 050711 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 250MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 1996/07/18 ÉêÇë»ú¹¹ PFIZER INC 6 Ò©Æ·Ãû³Æ ZITHROMAX ÉêÇëºÅ 050730 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 600MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ÊÇ Åú×¼ÈÕÆÚ 1996/06/12 ÉêÇë»ú¹¹ PFIZER CENTRAL RESEARCH 7 Ò©Æ·Ãû³Æ ZITHROMAX ÉêÇëºÅ 050733 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ INJECTABLE; INJECTION ¹æ¸ñ EQ 500MG BASE/VIAL ÖÎÁƵÈЧ´úÂë AP ²Î±ÈÒ©Îï ÊÇ Åú×¼ÈÕÆÚ 1997/01/30 ÉêÇë»ú¹¹ PFIZER INC 8 Ò©Æ·Ãû³Æ TROVAN/ZITHROMAX COMPLIANCE PAK ÉêÇëºÅ 050762 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN DIHYDRATE; TROVAFLOXACIN MESYLATE Êг¡×´Ì¬ Í£Ö¹ÉÏÊÐ ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ FOR SUSPENSION, TABLET; ORAL ¹æ¸ñ EQ 1GM BASE,N/A;N/A,EQ 100MG BASE ÖÎÁƵÈЧ´úÂë ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 1998/12/18 ÉêÇë»ú¹¹ PFIZER PHARMACEUTICALS INC 9 Ò©Æ·Ãû³Æ ZITHROMAX ÉêÇëºÅ 050784 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 500MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2002/05/24 ÉêÇë»ú¹¹ PFIZER INC 10 Ò©Æ·Ãû³Æ ZMAX ÉêÇëºÅ 050797 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ FOR SUSPENSION, EXTENDED RELEASE; ORAL ¹æ¸ñ EQ 2GM BASE/BOT ÖÎÁƵÈЧ´úÂë ²Î±ÈÒ©Îï ÊÇ Åú×¼ÈÕÆÚ 2005/06/10 ÉêÇë»ú¹¹ PFIZER GLOBAL RESEARCH DEVELOPMENT |
3Â¥2010-09-15 10:26:24
tianhua1211
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 21344.9
- ºì»¨: 2
- Ìû×Ó: 1835
- ÔÚÏß: 116.7Сʱ
- ³æºÅ: 951853
- ×¢²á: 2010-02-03
- ÐÔ±ð: MM
- רҵ: Ò©Îï×ÊÔ´
|
21 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065218 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 600MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2005/11/14 ÉêÇë»ú¹¹ PLIVA INC 22 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065223 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 500MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2005/11/14 ÉêÇë»ú¹¹ PLIVA INC 23 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065225 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 250MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2005/11/14 ÉêÇë»ú¹¹ PLIVA INC 24 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065246 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ FOR SUSPENSION; ORAL ¹æ¸ñ EQ 200MG BASE/5ML ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2006/07/05 ÉêÇë»ú¹¹ PLIVA INC 25 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065246 ²úÆ·ºÅ 002 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ FOR SUSPENSION; ORAL ¹æ¸ñ EQ 100MG BASE/5ML ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2006/07/05 ÉêÇë»ú¹¹ PLIVA INC 26 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065265 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ INJECTABLE; INJECTION ¹æ¸ñ EQ 500MG BASE/VIAL ÖÎÁƵÈЧ´úÂë AP ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2007/01/18 ÉêÇë»ú¹¹ PLIVA HRVATSKA DOO 27 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065297 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ FOR SUSPENSION; ORAL ¹æ¸ñ EQ 100MG BASE/5ML ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2006/09/18 ÉêÇë»ú¹¹ SANDOZ INC 28 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065297 ²úÆ·ºÅ 002 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ FOR SUSPENSION; ORAL ¹æ¸ñ EQ 200MG BASE/5ML ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2006/09/18 ÉêÇë»ú¹¹ SANDOZ INC 29 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065302 ²úÆ·ºÅ 003 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 600MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2008/02/11 ÉêÇë»ú¹¹ WOCKHARDT LTD 30 Ò©Æ·Ãû³Æ AZITHROMYCIN ÉêÇëºÅ 065360 ²úÆ·ºÅ 001 »îÐÔ³É·Ö AZITHROMYCIN Êг¡×´Ì¬ ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ TABLET; ORAL ¹æ¸ñ EQ 600MG BASE ÖÎÁƵÈЧ´úÂë AB ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ 2007/01/08 ÉêÇë»ú¹¹ MYLAN PHARMACEUTICALS INC |
5Â¥2010-09-15 10:27:54













»Ø¸´´ËÂ¥